Found: 14
Select item for more details and to access through your institution.
Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 755, doi. 10.1111/dom.12665
- By:
- Publication type:
- Article
Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 766, doi. 10.1111/dom.12666
- By:
- Publication type:
- Article
Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study ( VISION).
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 775, doi. 10.1111/dom.12667
- By:
- Publication type:
- Article
Relationship of body mass index with efficacy of exenatide twice daily added to insulin glargine in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 829, doi. 10.1111/dom.12669
- By:
- Publication type:
- Article
Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 812, doi. 10.1111/dom.12684
- By:
- Publication type:
- Article
Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 820, doi. 10.1111/dom.12687
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 735, doi. 10.1111/dom.12564
- Publication type:
- Article
Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 783, doi. 10.1111/dom.12670
- By:
- Publication type:
- Article
Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 834, doi. 10.1111/dom.12671
- By:
- Publication type:
- Article
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 795, doi. 10.1111/dom.12672
- By:
- Publication type:
- Article
Change in glycated haemoglobin levels after initiating second-line therapy in type 2 diabetes: a primary care database study.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 840, doi. 10.1111/dom.12673
- By:
- Publication type:
- Article
Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26-week, open-label, randomized, active comparator clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 803, doi. 10.1111/dom.12674
- By:
- Publication type:
- Article
Interchangeability among reference insulin analogues and their biosimilars: regulatory framework, study design and clinical implications.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 737, doi. 10.1111/dom.12676
- By:
- Publication type:
- Article
Role of E3 ubiquitin ligases in insulin resistance.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 747, doi. 10.1111/dom.12677
- By:
- Publication type:
- Article